Veterinary Medicines Information website

Eurican Piro, liofilizado e solvente para suspensão injetável

Authorised
  • Babesia canis, subsp. canis, strain BC 14-9, soluble parasite antigen

Product identification

Medicine name:
Eurican Piro, liofilizado e solvente para suspensão injetável
Active substance:
  • Babesia canis, subsp. canis, strain BC 14-9, soluble parasite antigen
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Babesia canis, subsp. canis, strain BC 14-9, soluble parasite antigen
Pharmaceutical form:
  • Lyophilisate for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AO
Authorisation status:
  • Valid
Authorised in:
  • Portugal
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health Portugal Unipessoal Lda.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Directorate General For Food And Veterinary
Authorisation number:
  • 347/90DGV
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Portuguese (PDF)
Published on: 13/07/2022
Updated on: 14/03/2026